{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T19:19:03Z","timestamp":1767554343368},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s12032-011-0011-0","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:29:19Z","timestamp":1309220959000},"page":"2176-2182","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic factors of Chinese patients with T\/NK-cell lymphoma: a single institution study of 170 patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Peng-Peng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","year":"1997","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood. 1997;89:3909\u201318.","journal-title":"Blood"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","volume":"9","author":"JR Anderson","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol. 1998;9:717\u201320.","journal-title":"Ann Oncol"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0046-8177(88)80217-X","volume":"19","author":"CS Ng","year":"1988","unstructured":"Ng CS, Chan JK. Malignant lymphomas in Chinese: what is the east\u2013west difference? Hum Pathol. 1988;19:614\u20135.","journal-title":"Hum Pathol"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, Muller-Hermelink HK. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol. 2002;13:140\u20139.","journal-title":"Ann Oncol"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","volume":"1","author":"B Coiffier","year":"1990","unstructured":"Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, Diebold J. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d\u2019Etude des Lymphomes Agressives). Ann Oncol. 1990;1:45\u201350.","journal-title":"Ann Oncol"},{"key":"11_CR6","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C, Cazals-Hatem D, Bosly A, Xerri L, Tilly H, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA). Blood. 1998;92:76\u201382.","journal-title":"Blood"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","volume":"89","author":"A Melnyk","year":"1997","unstructured":"Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma. Blood. 1997;89:4514\u201320.","journal-title":"Blood"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.1989.7.12.1783","volume":"7","author":"JO Armitage","year":"1989","unstructured":"Armitage JO, Vose JM, Linder J, Weisenburger D, Harrington D, Casey J, Bierman P, Sorensen S, Hutchins M, Moravec DF, et al. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol. 1989;7:1783\u201390.","journal-title":"J Clin Oncol"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ajcp\/83.3.279","volume":"83","author":"TM Grogan","year":"1985","unstructured":"Grogan TM, Fielder K, Rangel C, Jolley CJ, Wirt DP, Hicks MJ, Miller TP, Brooks R, Greenberg B, Jones S. Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes. Am J Clin Pathol. 1985;83:279\u201388.","journal-title":"Am J Clin Pathol"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","year":"1993","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987\u201394.","journal-title":"N Engl J Med"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103:2474\u20139.","journal-title":"Blood"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escalon","year":"2005","unstructured":"Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL, Dang NH. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer. 2005;103:2091\u20138.","journal-title":"Cancer"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/10428190601123989","volume":"48","author":"BB Park","year":"2007","unstructured":"Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, Kim HJ, Oh SY, Ko YH, Huh JR, et al. Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma. 2007;48:716\u201322.","journal-title":"Leuk Lymphoma"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J, Bendandi M, Albo C, Caballero MD. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol. 2007;18:652\u20137.","journal-title":"Ann Oncol"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.leukres.2010.08.006","volume":"35","author":"B Beltran","year":"2011","unstructured":"Beltran B, Quinones P, Morales D, Cotrina E, Castillo JJ. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia\/lymphoma. Leuk Res. 2011;35:334\u20139.","journal-title":"Leuk Res."},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1055-9965.EPI-06-1056","volume":"16","author":"EA Engels","year":"2007","unstructured":"Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:401\u20134.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030\u201344.","journal-title":"Int J Cancer"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB. Epstein-Barr virus: 40\u00a0years on. Nat Rev Cancer. 2004;4:757\u201368.","journal-title":"Nat Rev Cancer"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood.V80.7.1804.1804","volume":"80","author":"I Anagnostopoulos","year":"1992","unstructured":"Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, Gatter K, Dallenbach F, Parwaresch MR, Stein H. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood. 1992;80:1804\u201312.","journal-title":"Blood"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","volume":"108","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Emile JF, Mounier N, Gisselbrecht C, Martin-Garcia N, Petrella T, Bouabdallah R, Berger F, Delmer A, Coiffier B, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) study. Blood. 2006;108:4163\u20139.","journal-title":"Blood"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V81.10.2688.2688","volume":"81","author":"P Kanavaros","year":"1993","unstructured":"Kanavaros P, Lescs MC, Briere J, Divine M, Galateau F, Joab I, Bosq J, Farcet JP, Reyes F, Gaulard P. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993;81:2688\u201395.","journal-title":"Blood"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","volume":"353","author":"A Manns","year":"1999","unstructured":"Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet. 1999;353:1951\u20138.","journal-title":"Lancet"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","volume":"27","author":"X Liang","year":"2009","unstructured":"Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China\u2013declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550\u20137.","journal-title":"Vaccine"},{"key":"11_CR25","first-page":"554","volume":"91","author":"F Marcucci","year":"2006","unstructured":"Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A, Chionne P, Madonna E, Cotichini R, Barbui A, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin\u2019s lymphoma. Haematologica. 2006;91:554\u20137.","journal-title":"Haematologica"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1445-5994.2009.02060.x","volume":"40","author":"A Nath","year":"2010","unstructured":"Nath A, Agarwal R, Malhotra P, Varma S. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J. 2010;40:633\u201341.","journal-title":"Intern Med J"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","volume":"88","author":"Y Lee","year":"2009","unstructured":"Lee Y, Uhm JE, Lee HY, Park MJ, Kim H, Oh SJ, Jang JH, Kim K, Jung CW, Ahn YC, et al. Clinical features and prognostic factors of patients with \u201cperipheral T cell lymphoma, unspecified\u201d. Ann Hematol. 2009;88:111\u20139.","journal-title":"Ann Hematol"},{"key":"11_CR28","first-page":"1000","volume":"46","author":"YX Shi","year":"2007","unstructured":"Shi YX, Peng RJ, Lin SX, Wu QL, Lin TY, Sun XF, Huang HQ, Xia ZJ, Li YH, Xu RH, et al. A survival of 103 cases of T-cell non-Hodgkin lymphoma. Zhonghua Nei Ke Za Zhi. 2007;46:1000\u20132.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2005.05478.x","volume":"129","author":"R Sonnen","year":"2005","unstructured":"Sonnen R, Schmidt WP, Muller-Hermelink HK, Schmitz N. The international prognostic index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol. 2005;129:366\u201372.","journal-title":"Br J Haematol"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, Muller-Hermelink HK. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol. 2002;13:140.","journal-title":"Ann Oncol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hon.853","volume":"26","author":"N Niitsu","year":"2008","unstructured":"Niitsu N, Okamoto M, Nakamine H, Aoki S, Motomura S, Hirano M. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas. Hematol Oncol. 2008;26:152\u20138.","journal-title":"Hematol Oncol"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045","volume":"87","author":"F d\u2019Amore","year":"1996","unstructured":"d\u2019Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein-Barr virus genome in non-Hodgkin\u2019s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood. 1996;87:1045\u201355.","journal-title":"Blood"},{"key":"11_CR33","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T, Paulli M, et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol. 2006;24:2472\u20139.","journal-title":"J Clin Oncol"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.0902-4441.2005.00575.x","volume":"76","author":"Y Hirose","year":"2006","unstructured":"Hirose Y, Masaki Y, Sawaki T, Shimoyama K, Karasawa H, Kawabata H, Fukushima T, Ogawa N, Wano Y, Umehara H. Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan. Eur J Haematol. 2006;76:109\u201318.","journal-title":"Eur J Haematol"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3816\/CLM.2000.n.002","volume":"1","author":"R Liang","year":"2000","unstructured":"Liang R. Diagnosis and management of primary nasal lymphoma of T-cell or NK-cell origin. Clin Lymphoma. 2000;1:33\u20137. discussion 38.","journal-title":"Clin Lymphoma"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.10094","volume":"70","author":"W Mitarnun","year":"2002","unstructured":"Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease\/lymphoma: clinicopathologic, serologic, and molecular analysis. Am J Hematol. 2002;70:31\u20138.","journal-title":"Am J Hematol"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/JCM.10.1.75-79.1979","volume":"10","author":"J Nikoskelainen","year":"1979","unstructured":"Nikoskelainen J, Neel EU, Stevens DA. Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis. J Clin Microbiol. 1979;10:75\u20139.","journal-title":"J Clin Microbiol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-0011-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-011-0011-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-0011-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T22:04:54Z","timestamp":1592690694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-011-0011-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s12032-011-0011-0","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}